期刊文献+

KLK5基因在基底细胞样乳腺癌组织中的差异表达 被引量:3

Different expression of KLK5 genes in basal-like breast cancer
下载PDF
导出
摘要 目的:探索KLK5基因作为诊断基底细胞样乳腺癌(BLBC)的分子标志和治疗靶点的可能。方法:通过包含48 804个探针的人类mRNA基因表达谱芯片比较48例各亚型乳腺癌和6例正常乳腺组织基因表达谱,并通过荧光实时定量PCR法进行结果验证,分析BLBC与其他各亚型乳腺癌基因之间的差异表达。结果:分析乳腺癌各亚型和正常乳腺组织的基因表达谱,在BLBC中有99个基因上调4倍以上(2倍以上有意义),其中KLK5基因显著上调(5倍以上),但KLK5在Luminal A、Luminal B、HER-2过表达的基因表达谱中下调超过2倍,它们之间的差异表达具有统计学意义(P<0.05);并通过RT-PCR检测得到进一步验证。结论:KLK5可以作为诊断基底细胞样乳腺癌的标志基因和治疗靶点。 Objective: To investigate the underlying role of gene KLK5 as the therapeutic tar- gets for basal-like breast carcinoma. Methods: The gene-expression profiles of 48 cases of the breast carcinoma and 6 cases of normal mammary epithelium were analysed using human mRNA genome expression profiling chip containing 48 804 probes in attempt to characterize molecular mechanism involved in the carcinogenesis of basal-like carcinoma of the breast, Real time-PCR was also used to validate results of each of the breast carcinoma subtype tissues and normal mammary epithelium tissues. Reults: The mRNA gene expression profiling analysis of breast cancer mRNA and normal mammary ductal epithelial cells genomes expression profiling chips, it showed that 99 genes in BLBC upregulates more than 4-folds (more than 2-folds are indentified as significant), of these the gene KLK5 upregulates significantly (more than 5-folds).However, the gene KLK5 in Lu- minal A,Luminal B and HER2-positive breast cancer cells downregulates more than 2-folds, the dif- ferences have statistic significance (P〈O.05). RT-PCR and signaling network were further analyzed for the molecular regulation.The result is the same. Conclusion: It was found gene KLK5 in BLBC was significantly differed with other subtypes, such result has not been reported. It was assumed that KLK5 diferentially expressed gene could be used as a novel marker and a therapeutic target for BLBC.
出处 《中国现代普通外科进展》 CAS 2013年第9期673-677,共5页 Chinese Journal of Current Advances in General Surgery
基金 国家自然科学基金(30870975 81272905)
关键词 KLK5 乳腺肿瘤 MICRORNA 差异表达 KLKS. Breast neoplasms. MicroRNA Differentiated expresssion
  • 引文网络
  • 相关文献

参考文献18

  • 1马金平,曹明智,葛银林,马中良,柳晓义.FGFR2基因单核苷酸多态性与乳腺癌的相关性研究[J].中国现代普通外科进展,2011,14(2):111-115. 被引量:1
  • 2Perou CM. Molecular stratification of triple-negative breast caneers [J]. Oncologist, 2011,16(suppl 1 ):61-70.
  • 3Yu L, Yang W, Cai X, Shi D, et al. Centrally necrotizing carcinoma of the breast: clinieopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis [J]. Histopathology, 2010,57(2):193-201.
  • 4Pazaiti A, Fentiman IS. Basal phenotype breast cancer: implications for treatment and prognosis [J]. Womens Health (Lond Engl), 2011,7(2):181-202.
  • 5Ashburner M, Ball CA, Blake JA,et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium[J]. Nat Genet, 2000,25 ( 1 ) :25-29.
  • 6Binns D, Dimmer E, Huntley R, et al. QuickGO: a web-based tool for Gene Ontology searching[J]. Bioinformatics, 2009,25 (22):3045- 3046.
  • 7Carey L, Wirier E, Viale G, et al. Triple-negative breast cancer: disease entity or title of convenience [J]. Nat Rev Clin Oncol, 2010,7 (12) :683 -692.
  • 8Borgono CA, Michael IP, Komatsu N, et al. A potential role for mul- tiple tissue kallikrein serine proteases in epidermal desquamation[J] Biol Chem, 2007,282(6):3640-3652.
  • 9Mahn J, Hcllman J, Hogg P, el al. Enzymatic action of prostate-spe- cific antigen (PSA or hK3): substrate specificity and regulation by Zn (2+), a tight-binding inhibitor[J]. Prostate, 2000,45 (2): 132-139.
  • 10Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer[J]. Nat Rev Caneer, 2004,4( 11 ):876-890.

二级参考文献13

  • 1Gareia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics [J]. Plos Genet, 2008,25 (4): e1000054.
  • 2Jang JH, Shin KH, Park JG. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers[J]. Cancer Res, 2001, 61 (9):3541-3543.
  • 3Udler MS, Meyer KB, Pooley KA, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation[J]. Hum Mul Genet. 2009,18 (9):1692-1703.
  • 4Magklara A,Grass L,Diamandis EP.Differential steroid hormone regulation of human glandular kallikrein(hK2) and prostate-specific antigen (PSA) in breast cancer cell lines[J].Breast Cancer Research and Treatment,2000,59:263.
  • 5LeRoith D,Roberts CT.Role of insulin like growth factor Ⅰ receptor signaling in cancer[J].Cancer Lett,2003,195:127.
  • 6Michael IP,Pampalakis G,Magklara A,et al.Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5),a Novel Serine Protease Potentially Involved in Cancer Progression[J].J Bio Chem,2005,280(15):14628.
  • 7Yousef G M,Polymeris ME,GrassL,et al.Human Kallikrein 5:A Potential Novel Serum Biomarker for Breast and Ovarian Cancer[J].Cancer research,2003,63:5398.
  • 8Yousef G M,Diamandis EP.The new kallikrein-like gene,KLK-L2.Molecular characterization,mapping,tissue expression,and hormonal regulation[J].J Biol Chem,1999,274:37511.
  • 9Yousef G M,Obiezu C,Jung K,et al.Differential expression of kallikrein gene 5 (KLK5) in cancerous and normal testicular tissues[J].Urology,2002,60:714.
  • 10Rasmussen R.Quantification on the LightCycler.Rapid Cycle Real-time PCR Methods and Applicationsa[M].Springer Press,Heidelberg;2001.21.

共引文献2

同被引文献40

  • 1杜发茂,李相德,马晓燕,杜艳,杜文霞.SH2B1在非小细胞肺癌中的表达水平及与临床病理参数和预后的关系[J].热带医学杂志,2019,19(12):1507-1511. 被引量:2
  • 2陈英剑,胡成进,闻新棉,徐军,孙晓明.雌激素对人乳腺癌细胞株MCF-7 KLK6 mRNA和蛋白表达水平的影响[J].中国病理生理杂志,2007,23(2):246-249. 被引量:1
  • 3Mccracken M,Olsen M, Chen MS, et al. Cancer incidence,mortali- ty, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean and Japanese ethnicities [ J ]. CA Cancer J Clin,2007,57(4) : 190-205.
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 5Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs) : a gene family of novel cancer biomarkers[J]. Clin Chem Lab Med, 2012,50(11) : 1877-1891.
  • 6Yousef GM,Diamandis EP. The new human tissue kallikrein gene family., structure, function and association to disease[J]. Endocr Rev, 2001,22(2) : 184-204.
  • 7Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer[J]. Nat Rev Cancer,2004,4(11) :876-890.
  • 8Jin E, Fujiwara M, Pan X, et al. Protease-activated receptor(PAR)-I and PAR-2 participate in the cell growth of alveolar capillary endothe- lium in primary lung adenocarcinomas[J] Cancer, 2003,97 ( 3 ) : 703- 713.
  • 9Bay,s A,Tsetsenis T,Ventura S,et al. Human kallikrein 6 activi- ty is regulated via an autoproteolytic mechanism of activation/in- activation[J]. Biol Chem,2004,385(6) :517-524.
  • 10Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids [J]. Clin Chem, 2007,53 (8) : 1423- 1432.

引证文献3

二级引证文献6

;
使用帮助 返回顶部